Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Nov 02, 2020 1:00 PM - Nov 04, 2020 4:25 PM

(Central Europe Standard Time)

4051 Basel, Switzerland

Pharmacovigilance Strategies Workshop

Navigating the changing PV landscape in your daily work


DIA’s mission – to work across the healthcare continuum to ensure patients receive the therapies they need – is more essential than ever during times like these. DIA acknowledges the time and effort that has gone into planning and preparing for DIA’s Pharmacovigilance Strategies Workshop, and trusts that everyone will understand the need to respond to current, evolving health concerns in a responsible manner. These precautions are being taken to ensure the health and safety of our entire, global DIA family.

DIA is committed to exploring all possible avenues to provide a productive setting and a fulfilling meeting experience. We appreciate your patience as we work through any potential challenges.

 DIA has a long history of working closely with Industry and Regulators to bring topics and speakers together with broad audiences in order to create stimulating and relevant discussion.

Join the DIA Pharmacovigilance Strategies Workshop to discuss the current landscape and join intense and well-lead discussion that may help you to progress your knowledge and practices.

The conference format is designed to stimulate dialogue and generate solutions through a series of interactive sessions and workshops conducted in an informal setting allowing for in-depth discussion in smaller groups. 

Featured topics

  • EMA GVPs Updates
  • Medical Device Regulation: Impact on Pharmacovigilance
  • Implementation of EU Clinical Trial Regulation
  • Inspections and Audits
  • Signalling Management
  • Additional Pharmacovigilance Activities
  • Risk Minimisation Measures and Risk Communication
  • Future of Pharmacovigilance

Who should attend?

Established professionals who are seeking to increase their network of like-minded colleagues; share their thoughts and practices with others; learn the most current regulatory views and gain practical knowledge in key areas in pharmacovigilance, including:

  • Signal management
  • Data Privacy
  • Risk Management Planning
  • PSMF maintenance
  • Clinical Trials

Professionals involved in:

  • Drug Safety/Pharmacovigilance
  • Risk Management, including Risk Evaluation and Mitigation Strategies (REMS)
  • Benefit-risk assessment and communication
  • Medical Product Safety Assessment
  • Regulatory Affairs
  • Clinical Trials
  • Pharmaceuticals, biologics, combination products, devices
  • Clinical Research and Clinical Research Organizations
  • Health Outcomes
  • Academic Research Centers
  • Regulatory Agencies

Learning objectives

  • Seek direct answers to the business challenges you are facing every day
  • Understand how other organisations are managing through the shift of sharing all information to sharing relevant information
  • Understand the regulators expectations for signal assessment, risk management planning, and risk communication
  • Ensure that your pharmacovigilance work matches up with inspector expectations and delivers the efficient outcomes for patients.

Short Course or Primer

To keep you at the forefront.

Oct 29, 2020


The PSMF in 2020 - General Developments In - and Outside Europe

Program Committee

  • Wendy  Huisman, PharmD
    Wendy Huisman, PharmD Director
    Vigifit, Netherlands
  • Shahin  Kauser
    Shahin Kauser Leading Senior Scientific Assessor
    MHRA, United Kingdom
  • Maarten  Lagendijk, MSc
    Maarten Lagendijk, MSc Deputy EU QPPV
    MSD, Netherlands
  • Bianca  Mulder, PharmD, MPharm, MSc
    Bianca Mulder, PharmD, MPharm, MSc Pharmacovigilance Assessor
    Medicines Evaluation Board, Netherlands
  • Elena  Popa, MPharm
    Elena Popa, MPharm Regulatory Policy and Innovation Lead
    Bayer, Switzerland
  • Francoise  Sillan, MD
    Francoise Sillan, MD EU1 UK QPPV
    Ipsen, France
  • Mette  Stockner, MD
    Mette Stockner, MD Senior Pharmacovigilance Director
    Savara ApS, Denmark
  • Willemijn  van der Spuij, MSc
    Willemijn van der Spuij, MSc Executive Director, WorldWide Patient Safety International, Europe
  • James  Whitehead, MBA, MSc
    James Whitehead, MBA, MSc Senior Director, Device & Digital Safety
    AstraZeneca, United Kingdom

Digital Learning Catalog

DIA Learning: eLearning Soultions

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.